06/13/2024 3:30 PM | Adib Deyaa (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:37 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:00 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:00 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:12 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 7:00 PM | Blaug Suzanne (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | EDWARDS JEFFREY L (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/06/2024 7:00 PM | Brennan Aoife (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | Cravatt Benjamin (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Ho Maykin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Lema Gerald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:46 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 8:55 PM | FibroGen (Filer)
| Form ARS | |
04/24/2024 4:01 PM | FibroGen (Filer)
| Form DEF 14A | |
04/24/2024 4:08 PM | FibroGen (Filer)
| Form DEFA14A | |
04/24/2024 3:15 PM | Adib Deyaa (Reporting) FibroGen (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/25/2024 4:58 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 6:06 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:17 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:18 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:19 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:33 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:28 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:29 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:37 PM | ARMISTICE CAPITAL, LLC (Filed by) FibroGen (Subject)
| Form SC 13G | |
02/05/2024 7:08 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 6:28 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:19 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:20 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:21 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 3:05 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:11 PM | FibroGen (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023 3:30 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 6:41 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 6:37 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:54 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:55 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:55 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 6:37 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 6:38 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Elon Musk: THIS will be bigger than Tesla (Ad) If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay. See all the details you need here. |
09/01/2023 4:31 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023 4:14 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 4:28 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 6:10 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 3:42 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2023 7:32 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2023 3:47 PM | FibroGen (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
07/19/2023 6:01 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 7:28 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2023 3:46 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 6:36 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 3:27 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 8:05 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 8:53 PM | FibroGen (Subject) Wettig Thane (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023 5:32 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4/A | |